NACDS sponsored the Missouri Pharmacists Association’s Day at the Capitol. MPA’s priority bill, HB 834 by Rep. Dale Wright (R) that regulates PBMs, passed the House and is pending referral to a Senate Committee. More information can be found here.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
COVID-19 vaccination reimbursement under Medicaid will be at the Medicare rate effective April 1, 2021. HF 1428/SF 1156 successfully passed both chambers and was signed by Gov. Jim Walz (D) on March 31.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
On March 31, 2021, Gov. Greg Gianforte (R) announced a directive to reduce barriers to vaccine administration in pharmacies across Montana. The directive permits pharmacists to use any qualified, licensed health care providers, under their scope of practice, to assist with the administration of COVID-19 vaccines for the remainder of the state of emergency and temporarily waives the current restriction on the number of pharmacy technicians a pharmacist may supervise for the administration of COVID-19 vaccines and associated administrative duties and procedures. The directive is in effect for the remainder of Montana’s state of emergency per Executive Order 2-2021.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy published a notice to announce its intentions to amend and adopt regulations under NAC 453 to establish standards for a computerized program to track controlled substance prescriptions. The rule would provide for the development of patient utilization reports and prescriber utilization reports, address the integration of and access to electronic health records, and address periodic board review and law enforcement access to reports.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
SB 2294, increasing the retail sales quantity from 2 grams to 2.4 grams of ephedrine, pseudoephedrine, or phenylpropanolamine base, was signed by Gov. Doug Burgum (R) on March 23, 2021.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Effective March 23, the Health Authority adopted a final rule amending regulations as follows:
Also in Oregon, Via a temporary rule effective March 24 and expiring September 19, 2021, the Board of Pharmacy amends regulations under OAR 855-041 to remove the limit of the number of epinephrine devices that may be dispensed to an entity. For COVID-19 vaccines, appropriate medical treatment for severe allergic reactions must be immediately available if an acute anaphylactic reaction occurs following administration of a COVID-19 vaccine.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
NACDS is asking members to call Rep. Stephanie Klick’s office, the Chair of the House Public Health Committee, urging her to schedule a hearing as soon as possible for TX HB 678 by Rep. Phil Cortez (D). Our message is that “there is an urgent need to permanently remove the administrative barriers allowing pharmacists to independently order and administer all immunizations to anyone 3 years of age or older without a prescription. Passing HB 678 will guarantee Texans get much better access to convenient, preventive health care.” Capitol Phone: (512) 463-0599; District Phone: (817) 281-0079 & Public Health Committee Phone: (512) 463-0806
Also in Texas, As the state opens COVID-19 vaccine eligibility to everyone age 16 and older, the Texas Department of State Health Services (DSHS) launched the Texas Public Health Vaccine Scheduler, giving people one place to sign up for a COVID-19 shot through multiple public health departments, including the eight DSHS public health regions, which provide public health services in nearly 200 Texas counties, and more than a dozen local health entities across the state.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
HB 2263, relating to the regulation of PBMs, advances to the desk of Gov. Jim Justice (R) for signature. Both the House of Representatives and the Senate adopted the Joint House and Senate Conference Committee Report and passed the bill. Among the various provisions is language establishing a reimbursement rate floor of NADAC (or WAC, if NADAC is not available) plus a $10.49 professional dispensing fee.
Also in West Virginia, SB 182, legislation enacting the Board of Pharmacy’s emergency rule related to the pharmacist and pharmacy intern authority to immunize, was approved by Gov. Jim Justice (R) on April 1. The emergency rule permits pharmacists and pharmacy interns to administer vaccines to adults listed in the CDC’s Recommended Adult Immunization Schedule as well as to individuals ages 11-17 years of age listed in the CDC’s Recommended Child and Adolescent Schedule according to a prescription and parental consent if there are no contraindications to the vaccine.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
The Board of Medical Examiners issued a final rule to adopt regulations under AAC 540-X-26 to establish requirements for collaborative practice agreements between physicians and pharmacists. The rule adds requirements for collaborative drug therapy management agreements, standards for physicians, reporting, patient care protocols, and the formulary and is effective April 12, 2021.
Also in Alabama, The Board of Pharmacy issued a final rule to amend regulations under AAC 680-X-2 to further specify the standards and requirements for approval of hospital and non-hospital pharmacy remote or off-site order entry, where prescriptions are filled by remotely accessing another pharmacy’s electronic database from outside the pharmacy. The rule is effective April 12, 2021.
Lastly in Alabama, The Board of Pharmacy also published a proposed rule to amend regulations under AAC 680-X-2 to clarify provisions on the non-disciplinary administrative penalty for late renewal of a license, permit, registration, certification, or similar document. A hearing is scheduled for April 21, 2021, in Birmingham. Comments to the proposed rule are due April 10, 2021.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.